The in vivo dermal absorption and metabolism of [4-14C] coumarin by rats and by human volunteers under simulated conditions of use in fragrances.

The disposition and metabolic fate of [4-14C]coumarin in a 70% aqueous ethanol solution was studied in male Lister Hooded rats after occluded dermal application and in three male volunteers after an exposure designed to simulate that which may be encountered when using an alcohol-based perfumed product. In both cases, the 6-h exposure was 0.02 mg/cm(2) (rats 0.023 mg/kg and humans 0.77 mg/kg). In both, coumarin was quickly absorbed, distributed and excreted in urine and feces, although fecal excretion of coumarin in humans was only 1% of the applied dose as opposed to 21% in rats. Total absorption was 72% of the applied dose with rats and 60% with humans. Peak plasma radioactivity in both was at 1 h. The mean plasma half-life of coumarin and metabolites was approximately 1.7 h for humans and 5 h for rats. In humans, coumarin was primarily metabolized to and excreted in urine as 7-hydroxycoumarin glucuronide and 7-hydroxycoumarin sulfate. Small amounts of unconjugated 7-hydroxycoumarin and o-hydroxyphenylacetic acid (o-HPAA) were also excreted. In rats, about twenty metabolites were present, but only o-HPAA was identified. These studies show the rat is a very poor model for humans and toxicity in the rat cannot be extrapolated to humans.

[1]  W A Ritschel,et al.  First-pass effect of coumarin in man. , 1979, International journal of clinical pharmacology and biopharmacy.

[2]  W. Ritschel,et al.  Percutaneous absorption of coumarin, griseofulvin and propranolol across human scalp and abdominal skin. , 1989, Methods and findings in experimental and clinical pharmacology.

[3]  R. T. Williams,et al.  THE INFLUENCE OF ENTEROHEPATIC CIRCULATION ON TOXICITY OF DRUGS * , 1965, Annals of the New York Academy of Sciences.

[4]  B. Lake,et al.  Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  R. Bronaugh,et al.  Percutaneous Absorption and Metabolism of Coumarin in Human and Rat Skin , 1997, Journal of applied toxicology : JAT.

[6]  D. G. Walters,et al.  Comparison of the metabolism and disposition of [3-14C]coumarin in the rat and marmoset (Callithrix jacchus). , 1989, Toxicology letters.

[7]  D. Egan,et al.  Rapid and sensitive determination of coumarin and 7-hydroxycoumarin and its glucuronide conjugate in urine and plasma by high-performance liquid chromatography. , 1992, Journal of chromatography.

[8]  D. Opdyke,et al.  Monographs on fragrance raw materials: Coumarin , 1974 .

[9]  A. Cohen.  Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. , 1979, Food and cosmetics toxicology.

[10]  A. Y. Leung,et al.  Encyclopedia of Common Natural Ingredients: Used in Food, Drugs, and Cosmetics , 1980 .

[11]  R. T. Williams,et al.  The Metabolism of [3-14C]Coumarin , 1961 .

[12]  J. Idle,et al.  Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6 , 1998, European Journal of Clinical Pharmacology.

[13]  C. Wiseman,et al.  Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. A. Hussain,et al.  Transdermal absorption and topical bioavailability of coumarin. , 1988, Methods and findings in experimental and clinical pharmacology.

[15]  S. Born,et al.  Synthesis and reactivity of coumarin 3,4-epoxide. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[16]  O Pelkonen,et al.  Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. , 1992, Pharmacogenetics.

[17]  U. Gundert-Remy,et al.  Determination of 2-hydroxyphenylacetic acid (2HPAA) in urine after oral and parenteral administration of coumarin by gas-liquid chromatography with flame-ionization detection. , 1998, Journal of pharmaceutical and biomedical analysis.

[18]  D. Egan,et al.  The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. , 1990, Drug metabolism reviews.

[19]  Horst Surburg,et al.  Common fragrance and flavor materials , 1985 .

[20]  R. C. Longland,et al.  Metabolism of Coumarin in Man , 1969, Nature.

[21]  S. Hotchkiss,et al.  Comparativein VitroSkin Absorption and Metabolism of Coumarin (1,2-Benzopyrone) in Human, Rat, and Mouse , 1997 .

[22]  C. Logothetis,et al.  Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  G. Simon,et al.  Effects of coumarin following perinatal and chronic exposure in Sprague-Dawley rats and CD-1 mice. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[24]  W. Ritschel,et al.  Pilot Study on Bioavailability of Coumarin and 7‐Hydroxycoumarin upon Peroral Administration of Coumarin in a Sustained‐Release Dosage Form , 1981, Journal of clinical pharmacology.

[25]  S. Born,et al.  Selective Clara cell injury in mouse lung following acute administration of coumarin. , 1998, Toxicology and applied pharmacology.